Patents by Inventor Jose Berdoz

Jose Berdoz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070116725
    Abstract: Disclosed herein methods for producing live attenuated Salmonella typhi, Salmonella paratyphi A and B and other Salmonella mutants which can be used in vaccines to prevent diseases caused by Salmonella infection. These mutants can also be used to prevent or treat diseases caused by other bacterial strains, by viral and parasitic pathogens and by tumor cells.
    Type: Application
    Filed: December 5, 2006
    Publication date: May 24, 2007
    Inventors: Ion Vladoianu, Jose Berdoz
  • Publication number: 20050180985
    Abstract: Disclosed herein methods for producing live attenuated Salmonella typhi, Salmonella paratyphi A and B and other Salmonella mutants which can be used in vaccines to prevent diseases caused by Salmonella infection. These mutants can also be used to prevent or treat diseases caused by other bacterial strains, by viral and parasitic pathogens and by tumor cells.
    Type: Application
    Filed: November 5, 2001
    Publication date: August 18, 2005
    Inventors: Ion Vladoianu, Jose Berdoz
  • Publication number: 20030068328
    Abstract: Disclosed herein methods for producing live attenuated Salmonella typhi, Salmonella paratyphi A and B and other Salmonella mutants which can be used in vaccines to prevent diseases caused by Salmonella infection. These mutants can also be used to prevent or treat diseases caused by other bacterial strains, by viral and parasitic pathogens and by tumor cells.
    Type: Application
    Filed: November 5, 2001
    Publication date: April 10, 2003
    Inventors: Ion R. Vladoianu, Jose A. Berdoz
  • Patent number: 6258529
    Abstract: The invention features methods for isolating immunoglobulin variable region genes, and the use of these genes in the production of chimeric and isotype switched antibodies. The invention also features substantially pure DNA encoding a variable region of the antibody produced by hybridoma cell line HNK-20, and chimeric antibodies containing this variable region.
    Type: Grant
    Filed: December 1, 1994
    Date of Patent: July 10, 2001
    Assignee: OraVax, Inc.
    Inventors: José Berdoz, Jean-Pierre Kraehenbuhl